Aflibercept IVT

BIOLOGICAL2 trials

Sponsors

4D Molecular Therapeutics

Conditions

Diabetic Macular EdemaDiabetic RetinopathyNeovascular (Wet) Age-Related Macular Degeneration

Phase 1

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

RecruitingNCT05197270

4D Molecular TherapeuticsNeovascular (Wet) Age-Related Macular Degeneration

Start: 2021-12-09End: 2031-01-01Target: 215Updated: 2026-08-21

Phase 2

4D-150 in Patients With Diabetic Macular Edema

Active, not recruitingNCT05930561

4D Molecular TherapeuticsDiabetic Macular Edema, Diabetic Retinopathy

Start: 2023-08-09End: 2029-02-28Target: 72Updated: 2026-08-21